SCHEMBL4450271

SCHEMBL4450271

Nc1ccc(F)cc1.O=C(Nc1c[nH]nc1C(=O)O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.53
HDAC2 Q92769 3/20 0.49
CCNA2 P20248 1/20 0.48
CDK2 P24941 1/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
MAPT P10636 4/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.44
USP2 O75604 1/20 0.44
HPGD P15428 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HDAC3 O15379 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2799890 0.88 KMT2A (0.53) HDAC1CCNA2CDK2MEN1KMT2A
SCHEMBL3939511 0.87 LMNA (0.48) HDAC1MEN1KMT2ANPC1RAB9A
SCHEMBL2801723 0.87 KMT2A (0.54) HDAC1HDAC2CCNA2CDK2MEN1
SCHEMBL3942467 0.86 CDK2 (0.48) HDAC1CCNA2CDK2MEN1KMT2A
SCHEMBL3936265 0.84 KMT2A (0.47) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL954639 0.82 RAB9A (0.64) CCNA2CDK2MEN1KMT2ANPC1
SCHEMBL4442926 0.81 CDK2 (0.44) HDAC1CCNA2CDK2MEN1KMT2A
SCHEMBL2801400 0.81 L3MBTL1 (0.53) HDAC1MEN1KMT2ANPC1RAB9A
SCHEMBL3937911 0.80 KMT2A (0.43) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL3940057 0.79 ALDH1A1 (0.46) MEN1KMT2AMAPTALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049106-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-22 EP disclosed
WO-2008007113-A2 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed